Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven A Porcelli

Showing results (51-60 of 186) with videos related to

Pageof 19
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2007
CD1-restricted recognition of exogenous and self-lipid antigens by duodenal gammadelta+ T lymphocytesAnna M Russano, Gabrio Bassotti, Elisabetta Agea, et al.
Vaccine|March 30, 2010
Balancing safety and immunogenicity in live-attenuated mycobacterial vaccines for use in humans at risk for HIV: response to misleading comments in Ranganathan et al. "recombinant pro-apoptotic Mycobacterium tuberculosis generates CD8+ T cell responses against human immunodeficiency virus type 1 Env and M. tuberculosis in neonatal mice"Michelle H Larsen, William R Jacobs, Steven A Porcelli, et al.
Vaccine|October 8, 2009
Recombinant pro-apoptotic Mycobacterium tuberculosis generates CD8+ T cell responses against human immunodeficiency virus type 1 Env and M. tuberculosis in neonatal miceUma Devi K Ranganathan, Michelle H Larsen, John Kim, et al.
Bioorganic & Medicinal Chemistry Letters|June 2, 2009
Synthesis and evaluation of an acyl-chain unsaturated analog of the Th2 biasing, immunostimulatory glycolipid, OCHGeetha Velmourougane, Ravinder Raju, Gabriel Bricard, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2013
Human CD1d knock-in mouse model demonstrates potent antitumor potential of human CD1d-restricted invariant natural killer T cellsXiangshu Wen, Ping Rao, Leandro J Carreño, et al.
Bioorganic & Medicinal Chemistry Letters|June 2, 2012
New CD1d agonists: synthesis and biological activity of 6″-triazole-substituted α-galactosyl ceramidesPeter J Jervis, Lisa M Graham, Erin L Foster, et al.
Infection and Immunity|September 29, 2020
Identification of Autophagy-Inhibiting Factors of Mycobacterium tuberculosis by High-Throughput Loss-of-Function ScreeningEmily J Strong, Kristen L Jurcic Smith, Neeraj K Saini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2002
Induction of CD1-restricted immune responses in guinea pigs by immunization with mycobacterial lipid antigensKenji Hiromatsu, Christopher C Dascher, Kenneth P LeClair, et al.
Brain Pathology (Zurich, Switzerland)|February 13, 2003
Upregulation of group 1 CD1 antigen presenting molecules in guinea pigs with experimental autoimmune encephalomyelitis: an immunohistochemical studyBarbara Cipriani, Lanfen Chen, Kenji Hiromatsu, et al.
Frontiers in Immunology|October 20, 2022
A humanized mouse model for <i>in vivo</i> evaluation of invariant Natural Killer T cell responsesNoemi Alejandra Saavedra-Avila, Paolo Dellabona, Giulia Casorati, et al.
Pageof 19

Showing results (51-60 of 186) with videos related to

Sort By:
Pageof 19
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2007
CD1-restricted recognition of exogenous and self-lipid antigens by duodenal gammadelta+ T lymphocytesAnna M Russano, Gabrio Bassotti, Elisabetta Agea, et al.
Vaccine|March 30, 2010
Balancing safety and immunogenicity in live-attenuated mycobacterial vaccines for use in humans at risk for HIV: response to misleading comments in Ranganathan et al. "recombinant pro-apoptotic Mycobacterium tuberculosis generates CD8+ T cell responses against human immunodeficiency virus type 1 Env and M. tuberculosis in neonatal mice"Michelle H Larsen, William R Jacobs, Steven A Porcelli, et al.
Vaccine|October 8, 2009
Recombinant pro-apoptotic Mycobacterium tuberculosis generates CD8+ T cell responses against human immunodeficiency virus type 1 Env and M. tuberculosis in neonatal miceUma Devi K Ranganathan, Michelle H Larsen, John Kim, et al.
Bioorganic & Medicinal Chemistry Letters|June 2, 2009
Synthesis and evaluation of an acyl-chain unsaturated analog of the Th2 biasing, immunostimulatory glycolipid, OCHGeetha Velmourougane, Ravinder Raju, Gabriel Bricard, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2013
Human CD1d knock-in mouse model demonstrates potent antitumor potential of human CD1d-restricted invariant natural killer T cellsXiangshu Wen, Ping Rao, Leandro J Carreño, et al.
Bioorganic & Medicinal Chemistry Letters|June 2, 2012
New CD1d agonists: synthesis and biological activity of 6″-triazole-substituted α-galactosyl ceramidesPeter J Jervis, Lisa M Graham, Erin L Foster, et al.
Infection and Immunity|September 29, 2020
Identification of Autophagy-Inhibiting Factors of Mycobacterium tuberculosis by High-Throughput Loss-of-Function ScreeningEmily J Strong, Kristen L Jurcic Smith, Neeraj K Saini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2002
Induction of CD1-restricted immune responses in guinea pigs by immunization with mycobacterial lipid antigensKenji Hiromatsu, Christopher C Dascher, Kenneth P LeClair, et al.
Brain Pathology (Zurich, Switzerland)|February 13, 2003
Upregulation of group 1 CD1 antigen presenting molecules in guinea pigs with experimental autoimmune encephalomyelitis: an immunohistochemical studyBarbara Cipriani, Lanfen Chen, Kenji Hiromatsu, et al.
Frontiers in Immunology|October 20, 2022
A humanized mouse model for <i>in vivo</i> evaluation of invariant Natural Killer T cell responsesNoemi Alejandra Saavedra-Avila, Paolo Dellabona, Giulia Casorati, et al.
Pageof 19